The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?
Open accessAbstract
During the process of oncogenic transformation, melanoma cells escape from normal growth‐control mechanisms and acquire the ability to invade surrounding tissues and organs. The Ras/Raf/MEK/ERK pathway is a major pathway involved in the control of growth signals, cell survival and invasion. Melanomas are known to harbour activating mutations of both Ras and BRAF, suggesting that the downstream effector ERK may be playing a major role in the oncogenic behaviour of these tumours. The past few years have seen a growth in the understanding of the role of ERK and the MAP kinase pathway in melanoma. The aim of the current review is to assess the role of ERK in melanoma behaviour and to determine whether modulation of these kinases could offer new therapeutic opportunities. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Cowley, S. (1994) · Cell · doi:10.1016/0092-8674(94)90133-3 · Cited by 1,966
Integrins: Emerging Paradigms of Signal Transduction
Schwartz, M. A., Schaller, M. D., & Ginsberg, M. H. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.003001 · Cited by 1,594
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
Kölch, W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510289 · Cited by 1,441
Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., & Ahn, N. G. (1994) · Science · doi:10.1126/science.8052857 · Cited by 1,353
Raf-1 activates MAP kinase-kinase
Kyriakis, J. M., App, H., Zhang, X.-F., Banerjee, P., Brautigan, D. L., Rapp, U. R., & Avruch, J. (1992) · Nature · doi:10.1038/358417a0 · Cited by 1,283
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
BRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048
Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation.
Pagès, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., & Pouysségur, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8319 · Cited by 984
Activation of Raf as a Result of Recruitment to the Plasma Membrane
Stokoe, D., Macdonald, S. G., Cadwallader, K., Symons, M., & Hancock, J. F. (1994) · Science · doi:10.1126/science.7811320 · Cited by 976
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
The Primary Structure of MEK, a Protein Kinase that Phosphorylates the ERK Gene Product
Crews, C. M., Alessandrini, A., & Erikson, R. L. (1992) · Science · doi:10.1126/science.1411546 · Cited by 913
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
Cobb, M. H. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00056-x · Cited by 875
Albelda, S. M., Mette, S. A., Elder, D. E., Stewart, R., Damjanovich, L., Herlyn, M., & Buck, C. A. (1990) · PubMed · Cited by 760
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760
Ternary complex factors: growth factor regulated transcriptional activators
Treisman, R. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90097-3 · Cited by 676
Activation of Mitogen-Activated Protein Kinase Kinase by v-Raf in NIH 3T3 Cells and in Vitro
Dent, P., Haser, W., Haystead, T. A. J., Vincent, L. A., Roberts, T. M., & Sturgill, T. W. (1992) · Science · doi:10.1126/science.1326789 · Cited by 668
Lenormand, P., Sardet, C., Pagès, G., L'Allemain, G., Brunet, A., & Pouysségur, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.5.1079 · Cited by 661
Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5598 · Cited by 639
MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes
Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T., & Fisher, D. E. (1998) · Nature · doi:10.1038/34681 · Cited by 630
Ghiso, J. A. A., Kovalski, K., & Ossowski, L. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.89 · Cited by 549
The INK4A/ARF locus and its two gene products.
Sharpless, N. E., & DePinho, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80004-5 · Cited by 533
Wu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M. A., Wells, A. G., Price, E. R., Fisher, D. Z., & Fisher, D. E. (2000) · Genes & Development · doi:10.1101/gad.14.3.301 · Cited by 527
Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes
Bertolotto, C., Abbe, P., Hemesath, T. J., Bille, K., Fisher, D. E., Ortonne, J.-P., & Ballotti, R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.827 · Cited by 512
Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage
Goding, C. R. (2000) · Genes & Development · doi:10.1101/gad.14.14.1712 · Cited by 471
High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1
Sewing, A., Wiseman, B., Lloyd, A. C., & Land, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5588 · Cited by 462
Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen.
Montgomery, A. M., Reisfeld, R. A., & Cheresh, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8856 · Cited by 448
Satyamoorthy, K., Li, G., Gerrero, M. R., Brose, M. S., Volpe, P., Weber, B. L., Belle, P. A. V., Elder, D. E., & Herlyn, M. (2003) · PubMed · Cited by 445
AUTOCRINE AND PARACRINE REGULATION BY CYTOKINES AND GROWTH FACTORS IN MELANOMA
Lázár-Molnár, E., Hegyesi, H., Tóth, S., & Falus, A. (2000) · Cytokine · doi:10.1006/cyto.1999.0614 · Cited by 416
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
Feramisco, J. R., Gross, M., Kamata, T., Rosenberg, M., & Sweet, R. W. (1984) · Cell · doi:10.1016/0092-8674(84)90531-2 · Cited by 389
Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides
Abdel-Malek, Z., Swope, V. B., Suzuki, I., Akcali, C., Harriger, M. D., Boyce, S. T., Urabe, K., & Hearing, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1789 · Cited by 377
Busca, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2900 · Cited by 326
Timing of cyclin D1 expression within G1 phase is controlled by Rho
Welsh, C. F., Roovers, K., Villanueva, J., Liu, Y., Schwartz, M. A., & Assoian, R. K. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-950 · Cited by 323
E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro
Tang, A., Eller, M. S., Hara, M., Yaar, M., Hirohashi, S., & Gilchrest, B. A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.4.983 · Cited by 293
Widlund, H. R., Horstmann, M. A., Price, E. R., Cui, J., Lessnick, S. L., Wu, M., He, X., & Fisher, D. E. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202049 · Cited by 291
Rimm, D. L., Caca, K., Hu, G., Harrison, F. B., & Fearon, E. R. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65278-9 · Cited by 283
N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
van 't Veer, L. J., Burgering, B. M., Versteeg, R., Boot, A. J., Ruiter, D. J., Osanto, S., Schrier, P. I., & Bos, J. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.3114 · Cited by 283
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.
Petitclerc, É., Strömblad, S., Schalscha, T. V., Mitjans, F., Piulats, J., Montgomery, A. M. P., Cheresh, D. A., & Brooks, P. C. (1999) · PubMed · Cited by 237
Persons, D. L., Yazlovitskaya, E. M., Cui, W., & Pelling, J. C. (1999) · PubMed · Cited by 237
Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes
Mattei, S., Colombo, M. P., Melani, C., Silvani, A., Parmiani, G., & Herlyn, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560617 · Cited by 235
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
Tsao, H., Zhang, X., Fowlkes, K., & Haluska, F. G. (2000) · PubMed · Cited by 234
Buscà, R., Bertolotto, C., Ortonne, J.-P., & Ballotti, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31824 · Cited by 231
Differential Effects of cAMP in Neurons and Astrocytes
Dugan, L. L., Kim, J. S., Zhang, Y., Bart, R. D., Sun, Y., Holtzman, D. M., & Gutmann, D. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25842 · Cited by 218
Ridley, A. J., Paterson, H. F., Noble, M., & Land, H. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02990.x · Cited by 216
Li, G., Schaider, H., Satyamoorthy, K., Hanakawa, Y., Hashimoto, K., & Herlyn, M. (2001) · Oncogene · doi:10.1038/sj.onc.1205034 · Cited by 212
FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 200
Englaro, W., Rezzonico, R., Durand-Clément, M., Lallemand, D., Ortonne, J.-P., & Ballotti, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24315 · Cited by 197
Englaro, W., Bertolotto, C., Buscà, R., Brunet, A., Pagès, G., Ortonne, J.-P., & Ballotti, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9966 · Cited by 185
p16Ink4a in Melanocyte Senescence and Differentiation
Sviderskaya, E. V. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.6.446 · Cited by 179
Genersch, E., Hayeß, K., Neuenfeld, Y., & Haller, H. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.23.4319 · Cited by 178
Hughes, A. E., Newton, V. E., Liu, X. Z., & Read, A. P. (1994) · Nature Genetics · doi:10.1038/ng0894-509 · Cited by 171
van Elsas, A., Zerp, S. F., van der Flier, S., Krüse, K. M., Aarnoudse, C. A., Hayward, N. K., Ruiter, D. J., & Schrier, P. I. (1996) · Europe PMC (PubMed Central) · Cited by 160
Satyamoorthy, K., Li, G., Vaidya, B., Patel, D., & Herlyn, M. (2001) · PubMed · Cited by 159
Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes
Imokawa, G., Yada, Y., & Kimura, M. (1996) · Biochemical Journal · doi:10.1042/bj3140305 · Cited by 157
Koo, H.-M., VanBrocklin, M. W., McWilliams, M. J., Leppla, S. H., Duesbery, N. S., & Woude, G. F. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052707699 · Cited by 154
Smalley, K. S. M., & Eisen, T. G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01726-9 · Cited by 152
Self-citationErhardt, P., Troppmair, J., Rapp, U. R., & Cooper, G. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5524 · Cited by 139
Lerner, A. B., Shiohara, T., Boissy, R. E., Jacobson, K. A., Lamoreux, M. L., & Moellmann, G. E. (1986) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12524353 · Cited by 138
Woods, D. B., Cherwinski, H. M., Venetsanakos, E., Bhat, A., Gysin, S., Humbert, M., Bray, P. F., Saylor, V., & McMahon, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3192-3205.2001 · Cited by 132
The α3β1 Integrin Is Involved in Melanoma Cell Migration and Invasion
Melchiori, A., Mortarini, R., Carlone, S., et al. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1223 · Cited by 119
E-cadherin expression in human melanoma
Danen, E. H. J., de Vries, T. J., Morandini, R., Ghanem, G., Ruiter, D. J., & van Muijen, G. (1996) · Melanoma Research · doi:10.1097/00008390-199604000-00007 · Cited by 117
Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes
Nesbit, M., Nesbit, H. K., Bennett, J., Andl, T., Hsu, M., Dejesus, E., McBrian, M., Gupta, A. R., Eck, S. L., & Herlyn, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203066 · Cited by 117
Absence of p53 Gene Mutations in Cutaneous Melanoma
Lübbe, J., Reichel, M., Burg, G., & Kleihues, P. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12381544 · Cited by 113
Imokawa, G., Kobayasi, T., & Miyagishi, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004346200 · Cited by 110
Natali, P. G., Bartolazzi, A., Cavaliere, R., Bigotti, A., & Nicotra, M. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540112 · Cited by 110
Response of mouse melanoma cells to melanocyte stimulating hormone
Wong, G. L., Pawelek, J. M., Sansone, M., & Morowitz, J. H. (1974) · Nature · doi:10.1038/248351a0 · Cited by 102
Smalley, K. S. M., & Eisen, T. G. (2003) · International Journal of Cancer · doi:10.1002/ijc.11064 · Cited by 100
Self-citationPoint mutations in the N-ras oncogene in malignant melanoma and congenital naevi
CARR, J., & Mackie, R. M. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08460.x · Cited by 99
Novel Ras antagonist blocks human melanoma growth
Jansen, B., Schlagbauer‐Wadl, H., Kahr, H., Heere‐Ress, E., Mayer, B. X., Eichler, H.-G., Pehamberger, H., Gana‐Weisz, M., Ben‐David, E., Kloog, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14019 · Cited by 95
Sensorineural Deafness and Pigmentation Genes
Price, E. R., & Fisher, D. E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00259-8 · Cited by 95
Mitogen- and Ultraviolet-B-Induced Signaling Pathways in Normal Human Melanocytes
Tada, A., Pereira, E., Beitner‐Johnson, D., Kavanagh, R. J., & ABDEL‐MALEK, Z. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01694.x · Cited by 93
Medrano, E. E., Im, S., Yang, F., & ABDEL‐MALEK, Z. A. (1995) · PubMed · Cited by 92
Cultured Human Melanocytes Respond to MSH Peptides and ACTH
HUNT, G., DONATIEN, P. D., Lunec, J., Todd, C., KYNE, S., & Thody, A. J. (1994) · Pigment Cell Research · doi:10.1111/j.1600-0749.1994.tb00052.x · Cited by 88
Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells
Kortylewski, M., Heinrich, P. C., Kauffmann, M.-E., Böhm, M., Mackiewicz, A. A., & Behrmann, I. (2001) · Biochemical Journal · doi:10.1042/bj3570297 · Cited by 86
Powell, M. B., Hyman, P., Bell, O. D., Balmain, A., Brown, K., Alberts, D., & Bowden, G. T. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940120205 · Cited by 84
Felding‐Habermann, B., Ruggeri, Z. M., & Cheresh, D. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42731-7 · Cited by 83
YANASE, H., Ando, H., Horikawa, M., Watanabe, M., Mori, T., & Matsuda, N. (2001) · Pigment Cell Research · doi:10.1034/j.1600-0749.2001.140205.x · Cited by 79
Cyclic AMP Blocks Cell Growth through Raf-1-Dependent and Raf-1-Independent Mechanisms
Dumaz, N., Light, Y., & Marais, R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3717-3728.2002 · Cited by 78
Role of the β3 Integrin Subunit in Human Primary Melanoma Progression
Seftor, R. E. B. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65719-7 · Cited by 71
SCOTT, G. A., & Cassidy, L. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00276.x · Cited by 70
Mitsui, H., Takuwa, N., Maruyama, T., Maekawa, H., Hirayama, M., Sawatari, T., Hashimoto, N., Takuwa, Y., & Kimura, S. (2001) · International Journal of Cancer · Cited by 70
The MEK1 inhibitor PD98059 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis
Mandic, A., Viktorsson, K., Heiden, T., Hansson, J., & Shoshan, M. C. (2001) · Melanoma Research · doi:10.1097/00008390-200102000-00002 · Cited by 67
Tower, G. B., Coon, C. C., Benbow, U., Vincenti, M. P., & Brinckerhoff, C. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00105-3 · Cited by 65
Jansen, B., Schlagbauer‐Wadl, H., Eichler, H. G., Wolff, K., van Elsas, A., Schrier, P. I., & Pehamberger, H. (1997) · PubMed · Cited by 64
Stadheim, T. A., & Kucera, G. L. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8410 · Cited by 63
Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
Pawelek, J. M., Sansone, M., Koch, N., Christie, G. E., Halaban, R., Hendee, J., Lerner, A. B., & Varga, J. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.951 · Cited by 63
Puyraimond, A., Weitzman, J. B., Babiole, E., & Ménashi, S. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.9.1283 · Cited by 62
The Ras AntagonistS-Farnesylthiosalicylic Acid Induces Inhibition of MAPK Activation
Gana‐Weisz, M., Haklai, R., Marciano, D., Egozi, Y., Ben‐Baruch, G., & Kloog, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7582 · Cited by 61
MEK1 Activation Rescues Jurkat T Cells from Fas-Induced Apoptosis
Wilson, D. J., Alessandrini, A., & Budd, R. C. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1486 · Cited by 58
Albino, A. P., Sozzi, G., Nanus, D. M., et al. (1992) · PubMed · Cited by 58
Lack ofp53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions
Papp, T., Jafari, M., & Schiffmann, D. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01213550 · Cited by 57
van Elsas, A., Zerp, S. F., van der Flier, S., Krüse-Wolters, M., Vacca, A., Ruiter, D. J., & Schrier, P. I. (1995) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-78771-3_5 · Cited by 55
Santibanez, J. F., Iglesias, M., Frontelo, P., Martı́nez, J., & Quintanilla, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2946 · Cited by 55
Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors
Storm, S. M., & Rapp, U. R. (1993) · Toxicology Letters · doi:10.1016/0378-4274(93)90056-4 · Cited by 53
Denkert, C., Siegert, A., Leclere, A., Turzynski, A., & Hauptmann, S. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1013857325012 · Cited by 50
Smalley, K. S. M., & Eisen, T. G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10213 · Cited by 46
Self-citationSmalley, K. S. M., & Eisen, T. G. (2002) · Melanoma Research · doi:10.1097/00008390-200206000-00001 · Cited by 34
Self-citationEndothelin-1 Decreases Basic Apoptotic Rates in Human Melanoma Cell Lines
Eberle, J., Fecker, L. F., Orfanos, C. E., & Geilen, C. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01848.x · Cited by 33
DONATIEN, P. D., Diment, S., Boissy, R. E., & Orlow, S. J. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960516)66:4<557::aid-ijc22>3.0.co;2-3 · Cited by 21
Cited by
The MAPK signalling pathways and colorectal cancer
Fang, J. Y., & Richardson, B. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70168-6 · Cited by 1,185
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Skin melanocytes: biology and development
Cichorek, M., Wachulska, M., Stasiewicz, A., & Tymińska, A. (2013) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2013.33376 · Cited by 673
Boutros, T., Chevet, E., & Metrakos, P. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.00106 · Cited by 545
Smalley, K. S. M., Haass, N. K., Brafford, P. A., Lioni, M., Flaherty, K. T., & Herlyn, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0084 · Cited by 463
Self-citation
Metadata
- Authors
- Smalley, K. S. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2003-02-14
- Volume
- 104
- Issue
- 5
- Pages
- 527-532
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2047942701
- Cited by
- 325
- References
- 111
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.